General Oceans ASA Statistics
Total Valuation
OSL:GENO has a market cap or net worth of NOK 4.67 billion. The enterprise value is 4.66 billion.
| Market Cap | 4.67B |
| Enterprise Value | 4.66B |
Important Dates
The next confirmed earnings date is Monday, May 18, 2026.
| Earnings Date | May 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OSL:GENO has 187.61 million shares outstanding.
| Current Share Class | 187.61M |
| Shares Outstanding | 187.61M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 44.46% |
| Owned by Institutions (%) | 6.44% |
| Float | 49.97M |
Valuation Ratios
The trailing PE ratio is 35.39.
| PE Ratio | 35.39 |
| Forward PE | n/a |
| PS Ratio | 4.86 |
| PB Ratio | 6.50 |
| P/TBV Ratio | 11.56 |
| P/FCF Ratio | 40.76 |
| P/OCF Ratio | 35.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 37.54, with an EV/FCF ratio of 40.69.
| EV / Earnings | 118.91 |
| EV / Sales | 4.85 |
| EV / EBITDA | 37.54 |
| EV / EBIT | 71.09 |
| EV / FCF | 40.69 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.66 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 2.19 |
| Debt / FCF | 2.40 |
| Interest Coverage | 5.19 |
Financial Efficiency
Return on equity (ROE) is 5.83% and return on invested capital (ROIC) is 6.28%.
| Return on Equity (ROE) | 5.83% |
| Return on Assets (ROA) | 3.56% |
| Return on Invested Capital (ROIC) | 6.28% |
| Return on Capital Employed (ROCE) | 7.56% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.87M |
| Profits Per Employee | 117,311 |
| Employee Count | 334 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.45 |
Taxes
In the past 12 months, OSL:GENO has paid 21.48 million in taxes.
| Income Tax | 21.48M |
| Effective Tax Rate | 35.40% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 6,349,056 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSL:GENO had revenue of NOK 960.21 million and earned 39.18 million in profits. Earnings per share was 0.70.
| Revenue | 960.21M |
| Gross Profit | 640.40M |
| Operating Income | 67.32M |
| Pretax Income | 60.66M |
| Net Income | 39.18M |
| EBITDA | 110.17M |
| EBIT | 67.32M |
| Earnings Per Share (EPS) | 0.70 |
Balance Sheet
The company has 282.89 million in cash and 275.23 million in debt, with a net cash position of 7.66 million or 0.04 per share.
| Cash & Cash Equivalents | 282.89M |
| Total Debt | 275.23M |
| Net Cash | 7.66M |
| Net Cash Per Share | 0.04 |
| Equity (Book Value) | 718.39M |
| Book Value Per Share | 12.80 |
| Working Capital | 281.98M |
Cash Flow
In the last 12 months, operating cash flow was 130.17 million and capital expenditures -15.67 million, giving a free cash flow of 114.50 million.
| Operating Cash Flow | 130.17M |
| Capital Expenditures | -15.67M |
| Depreciation & Amortization | 42.85M |
| Net Borrowing | 24.03M |
| Free Cash Flow | 114.50M |
| FCF Per Share | 0.61 |
Margins
Gross margin is 66.69%, with operating and profit margins of 7.01% and 4.08%.
| Gross Margin | 66.69% |
| Operating Margin | 7.01% |
| Pretax Margin | 6.32% |
| Profit Margin | 4.08% |
| EBITDA Margin | 11.47% |
| EBIT Margin | 7.01% |
| FCF Margin | 11.92% |
Dividends & Yields
OSL:GENO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 25.52% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.84% |
| FCF Yield | 2.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OSL:GENO has an Altman Z-Score of 1.21 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 4 |